医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Half-dry ‘Gold Tongue Sole’ of Ariul Fish Becomes Popular as Home-cooked Dish to Make a Table Great

2020年12月22日 PM06:12
このエントリーをはてなブックマークに追加


 

SEOUL, South Korea

‘Gold Tongue Sole’, a half-dry fish product of Korea’s Ariul Fish LLC, is popular among working moms who prefer simple and easy to prepare meals due to busy life.

They are hesitant to go to restaurants due to the COVID-19 pandemic and face difficulty in deciding the menu for preparing meals at home every day.

Half-dry ‘gold tongue soles’ from Ariul Fish turn into an attractive main dish when their front and rear sides are yellowly grilled in an oiled pan. Containing less moisture as they are dried after removing innards, half-dry fishes are free from burning and take a shorter time in cooking. As they are properly salted, it is not needed to add salt.

Being caught mainly on the west coast of Gunsan, Jeollabuk-do in Korea, tongue soles are flat fishes that belong to the red tongue sole family. It contains a variety of nutrients, such as protein and minerals, with less smell and a fresh taste.

“Containing plenty of calcium and ingredients that help the absorption of calcium as well as iron, tongue soles help people prevent osteoporosis and enhance the health of bone,” said a manager at Ariul Fish. “As it is effective in numerous aspects, intake of tongue sole will be beneficial in winter when nutrients may be insufficient.”

In 2012, Ariul Fish registered ‘Love Sea-Gold Tongue Sole’ as a trademark with the Korean Intellectual Property Office. Having obtained the HACCP certification and selected as the Clean Factory by the Korea Gov., the company is assuredly focusing on quality management.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201222005234/en/

CONTACT

Ariul Fish LLC

Hyeon-gu Jeong

+82-63-443-3313

pko3313@naver.com

同じカテゴリーの記事 

  • Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop® System Images Across Multiple Care Settings and Clinical Conditions
  • ReNAgade Therapeutics宣布在ASGCT第27届年会上发表演讲
  • ReNAgade TherapeuticsがASGCT第27回年次総会でのプレゼンテーションの内容を発表
  • BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
  • The 2024 Japan Prize Award Ceremony Is Held with Their Majesties the Emperor and Empress of Japan in Attendance